Pemazyre European Union - Croatian - EMA (European Medicines Agency)

pemazyre

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastična sredstva - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

FARROWSURE PLUS B Croatia - Croatian - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

farrowsure plus b

pfizer croatia d.o.o., zagreb, hrvatska - parvovirus svinja, soj nadl-7; erysipelothrix rhusiopathiae, soj cn 3342; leptospira bratislava, soj jez; l. canicola, soj c-51; l.grippotyphosa, soj mal 1540; l.hatdjo, soj who; l. icterohaemorrhagiae, soj nadl (11403) i l. pomona, soj t262 - injekcijska emulzija - svinja

Ngenla European Union - Croatian - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - hipofize i ГИПОТАЛАМИЧЕСКИЕ hormoni i analozi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Rybrevant European Union - Croatian - EMA (European Medicines Agency)

rybrevant

janssen-cilag international n.v.    - amivantamab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) European Union - Croatian - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hipofiza i hipotalamusni hormoni i analozi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

ECANSYA 300mg Film tableta Montenegro - Croatian - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

ecansya 300mg film tableta

dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - kapecitabin - film tableta - 300mg

ECANSYA 500mg Film tableta Montenegro - Croatian - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

ecansya 500mg film tableta

dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - kapecitabin - film tableta - 500mg

ECANSYA 150mg Film tableta Montenegro - Croatian - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

ecansya 150mg film tableta

dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - kapecitabin - film tableta - 150mg

ECANSYA 300mg Film tableta Montenegro - Croatian - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

ecansya 300mg film tableta

dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - kapecitabin - film tableta - 300mg